Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rare Disease Therapeutics
Pharma
Orphan Cures Act dropped from Senate reconciliation bill
The Orphan Cures Act would allow drugs with multiple rare disease indications to be exempt from Medicare price negotiations.
Angus Liu
Jun 17, 2025 11:30am
Chiesi study highlights economic burden of rare diseases
Mar 14, 2022 11:33am
AI helps rare disease marketers reach elusive patients
Jan 19, 2022 8:30am
Inozyme rebrand features a fresher, more innovative, purple look
Dec 17, 2021 7:05am
Alexion kids' books aim to help parents explain rare diseases
Oct 29, 2021 8:13am
